GRFS vs SNY
Grifols SA and Sanofi, side by side — 10 fiscal years reported in EUR, drawn from SEC filings.
Most recent reported year
| Metric | GRFS | SNY |
|---|---|---|
| Revenue | €7.2B | €43.6B |
| Net income | €156.9M | €7.8B |
| Gross margin | 38.7% | 77.2% |
| Net margin | 3.0% | 18.0% |
| Return on equity | 2.8% | 10.5% |
| Diluted EPS | €0.23 | €6.37 |
| Dividend / share | · | €3.92 |
| Payout ratio | 0.6% | 61.1% |
| Free cash flow | €669.6M | · |
| Equity | €5.9B | €71.4B |
| Net debt / equity | · | 0.15× |
| Current ratio | 2.66× | 1.09× |
| Revenue CAGR 5y | 7.2% | 3.9% |
| Profit CAGR 5y | −24.2% | −8.7% |
SNY bills 6.0× the revenue of GRFS, and keeps more of each dollar of revenue as profit (18.0% against 3.0%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | GRFS | SNY |
|---|---|---|
| FY2024 | €7.2B | €41.1B |
| FY2023 | €6.6B | €37.8B |
| FY2022 | €6.1B | €37.7B |
| FY2021 | €4.9B | €37.8B |
| FY2020 | €5.3B | €36.0B |
| FY2019 | €5.1B | €36.1B |
| FY2018 | €4.5B | €34.5B |
| FY2017 | €4.3B | €35.1B |
| FY2016 | €4.0B | €33.8B |
| FY2015 | €3.9B | €34.1B |
Bottom line
| Fiscal year | GRFS | SNY |
|---|---|---|
| FY2024 | €156.9M | €5.6B |
| FY2023 | €42.3M | €5.4B |
| FY2022 | €185.0M | €8.4B |
| FY2021 | €188.7M | €6.2B |
| FY2020 | €618.5M | €12.3B |
| FY2019 | €625.1M | €2.8B |
| FY2018 | €596.6M | €4.3B |
| FY2017 | €662.7M | €8.4B |
| FY2016 | €545.5M | €4.7B |
| FY2015 | €532.1M | €4.3B |
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2024 | −€33,868,618,000 | SNY |
| FY2023 | −€31,225,023,000 | SNY |
| FY2022 | −€31,587,033,000 | SNY |
| FY2021 | −€32,827,882,000 | SNY |
| FY2020 | −€30,700,962,000 | SNY |
| FY2019 | −€31,027,309,000 | SNY |
| FY2018 | −€29,976,276,000 | SNY |
| FY2017 | −€30,753,927,000 | SNY |
| FY2016 | −€29,759,170,000 | SNY |
| FY2015 | −€30,125,437,000 | SNY |
SNY has reported the higher revenue in every one of these 10 fiscal years. The gap has widened since the earliest year compared.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2024 | −10.7 pp | SNY |
| FY2023 | −11.9 pp | SNY |
| FY2022 | −18.4 pp | SNY |
| FY2021 | −11.2 pp | SNY |
| FY2020 | −20.9 pp | SNY |
| FY2019 | +5.0 pp | GRFS |
| FY2018 | +0.5 pp | GRFS |
| FY2017 | −9.0 pp | SNY |
| FY2016 | −0.8 pp | SNY |
| FY2015 | +0.6 pp | GRFS |
The higher net margin has changed hands between GRFS and SNY over this period.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
SNY's net margin has been more volatile than GRFS's over the 10 comparable fiscal years — 7.3 percentage points of standard deviation against 4.9.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between GRFS and SNY over these 10 fiscal years — GRFS led in 3 and SNY in 7.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
GRFS's return on equity has been more volatile than SNY's over the 10 comparable fiscal years — 6.4 percentage points of standard deviation against 4.3.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between GRFS and SNY over these 10 fiscal years — GRFS led in 5 and SNY in 5.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.